Indoximod treatment significantly decreased TLR-4 expression to 2.20 ± 0.27 pg/mg compared with the colitis group (## p < 0.01; p = 0.001), suggesting effective inhibition of TLR4-driven inflammatory responses. The gene discussed is TLR4; the disease is colitis.